Blue Goose Capital
Investing in biopharma, data and device companies
Seed stage to Series B, US and Spain
-
Mythic Therapeutics Backed by $103 Million in Series B Financing
Mythic’s FateControl™ technology holds the potential to dramatically improve the therapeutic index of ADCs, independent of the linker and payload
-
Leuko Raises $5 Million Series A to Validate and Bring to Market Its Noninvasive White Blood Cell Monitoring Technology for Cancer Patients
Leuko, an MIT-born technology startup developing a non-invasive white blood cell monitoring device, raised $5 million Series A to validate and bring to market Its noninvasive white blood cell monitoring technology for cancer patients
-
Aluna Announces Series B Financing
Aluna has raised almost $19 million in funding. Though a prescription is not required, Aluna recommends consulting with one’s physician when using the Aluna platform.